Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?

Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nicole Tubiana-Mathieu, Thibault Cornette, Stephane Mandigout, Sophie Leobon, François Vincent, Laurence Venat, Elise Deluche
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6a7d92086b044f65b70ec44572b7db46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a7d92086b044f65b70ec44572b7db46
record_format dspace
spelling oai:doaj.org-article:6a7d92086b044f65b70ec44572b7db462021-11-25T17:04:43ZCan the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?10.3390/cancers132258512072-6694https://doaj.org/article/6a7d92086b044f65b70ec44572b7db462021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5851https://doaj.org/toc/2072-6694Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before and after adjuvant therapy. Of these patients, 85 had performed APA, and 53 had received only the usual therapy. HRs were recorded during the two tests. Results: Before starting chemotherapy, good agreement (intraclass correlation (ICC) 0.69; confidence interval at 95% IC<sub>0.95</sub> (0.591–0.769); <i>p</i> < 0.001) and a moderate correlation were evident between the 6MWT-HR and ventilatory threshold HR of the CPET (r = 0.70; <i>p</i> < 0.001). Good agreement and a high positive correlation were noted only in the group who engaged in APA (ICC 0.77; IC<sub>0.95</sub> (0.659–0.848); <i>p</i> < 0.001; r = 0.8; <i>p</i> < 0.01); moderate agreement and a moderate positive correlation were apparent in the control group (ICC 0.57; IC<sub>0.95</sub> (0.329–0.74); <i>p</i> < 0.001; r = 0.6; <i>p</i> < 0.01). The correlations were independent of age and body mass index. Conclusions: The 6MWT-HR can be used to prescribe exercise intensity for breast cancer patients both before and after specific treatment with concomitant APA.Nicole Tubiana-MathieuThibault CornetteStephane MandigoutSophie LeobonFrançois VincentLaurence VenatElise DelucheMDPI AGarticlecardiopulmonary testsix-minute walk testadapted physical activitybreast cancerhome trainingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5851, p 5851 (2021)
institution DOAJ
collection DOAJ
language EN
topic cardiopulmonary test
six-minute walk test
adapted physical activity
breast cancer
home training
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle cardiopulmonary test
six-minute walk test
adapted physical activity
breast cancer
home training
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Nicole Tubiana-Mathieu
Thibault Cornette
Stephane Mandigout
Sophie Leobon
François Vincent
Laurence Venat
Elise Deluche
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
description Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before and after adjuvant therapy. Of these patients, 85 had performed APA, and 53 had received only the usual therapy. HRs were recorded during the two tests. Results: Before starting chemotherapy, good agreement (intraclass correlation (ICC) 0.69; confidence interval at 95% IC<sub>0.95</sub> (0.591–0.769); <i>p</i> < 0.001) and a moderate correlation were evident between the 6MWT-HR and ventilatory threshold HR of the CPET (r = 0.70; <i>p</i> < 0.001). Good agreement and a high positive correlation were noted only in the group who engaged in APA (ICC 0.77; IC<sub>0.95</sub> (0.659–0.848); <i>p</i> < 0.001; r = 0.8; <i>p</i> < 0.01); moderate agreement and a moderate positive correlation were apparent in the control group (ICC 0.57; IC<sub>0.95</sub> (0.329–0.74); <i>p</i> < 0.001; r = 0.6; <i>p</i> < 0.01). The correlations were independent of age and body mass index. Conclusions: The 6MWT-HR can be used to prescribe exercise intensity for breast cancer patients both before and after specific treatment with concomitant APA.
format article
author Nicole Tubiana-Mathieu
Thibault Cornette
Stephane Mandigout
Sophie Leobon
François Vincent
Laurence Venat
Elise Deluche
author_facet Nicole Tubiana-Mathieu
Thibault Cornette
Stephane Mandigout
Sophie Leobon
François Vincent
Laurence Venat
Elise Deluche
author_sort Nicole Tubiana-Mathieu
title Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
title_short Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
title_full Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
title_fullStr Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
title_full_unstemmed Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
title_sort can the six-minute walk test be used to individualize physical activity intensity in patients with breast cancer?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6a7d92086b044f65b70ec44572b7db46
work_keys_str_mv AT nicoletubianamathieu canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT thibaultcornette canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT stephanemandigout canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT sophieleobon canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT francoisvincent canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT laurencevenat canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
AT elisedeluche canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer
_version_ 1718412716625887232